Encrantz Staffan → Sight Sciences, Inc. SGHT

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

5 transactions

0 buys · 5 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-07-15

DTC 5.03

829,847 shares short · +14.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $340K

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-06	HAYDEN JEREMY B.	officer	Sale	12,733	$5.51	$70K
2026-07-06	Badawi David	director, officer	Sale	7,418	$5.51	$41K
2026-07-02	Rodberg James	officer	Sale	6,902	$5.36	$37K
2026-07-02	Bauerlein Alison	officer	Sale	24,184	$5.36	$130K
2026-07-01	Taylor Brenton	officer	Sale	2,829	$5.42	$15K

Other 13D/G Filings on Sight Sciences, Inc.

Filed	Form	Filer	Stake	Shares
2025-03-13	SCHEDULE	Encrantz Staffan	13.10%	6,731,526	view →
2022-04-18	SC	SHD GP II, LLC	—	—	view →

Other Filings by Encrantz Staffan

Filed	Form	Issuer	Stake	Shares
2025-03-13	SCHEDULE	Sight Sciences, Inc. SGHT	13.10%	6,731,526	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →